The rapid progress in gene therapy within the Duchenne Muscular Dystrophy Treatment Market raises important ethical questions. While these therapies offer hope, concerns about long-term safety, genetic modification, and equitable access remain. Debates around consent, especially for pediatric patients, highlight the need for robust ethical guidelines. Transparency in clinical trial... https://www.marketresearchfuture.com/reports/duchenne-muscular-dystrophy-treatment-market-21953